CVE:SCYBScythian Biosciences Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Scythian Biosciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume231,491 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlinesSocial Media Scythian Biosciences Corp. engages in the research and development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. It also develops drug candidates for the treatment of gastro-intestinal inflammatory issues. The company is headquartered in Toronto, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Scythian Biosciences. Previous Next 2.6 Community Rank Outperform VotesScythian Biosciences has received 36 “outperform” votes. (Add your “outperform” vote.)Underperform VotesScythian Biosciences has received 32 “underperform” votes. (Add your “underperform” vote.)Community SentimentScythian Biosciences has received 52.94% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Scythian Biosciences and other stocks. Vote “Outperform” if you believe SCYB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SCYB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldScythian Biosciences does not currently pay a dividend.Dividend GrowthScythian Biosciences does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Scythian Biosciences insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.52 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:SCYB Previous Symbol CUSIPN/A CIKN/A Webscythianbio.com Phone+1-416-3669192Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable TSXV:SCYB Rates by TradingView Receive SCYB News and Ratings via Email Sign-up to receive the latest news and ratings for SCYB and its competitors with MarketBeat's FREE daily newsletter. Scythian Biosciences (CVE:SCYB) Frequently Asked Questions Has Scythian Biosciences been receiving favorable news coverage? Media stories about SCYB stock have been trending somewhat negative on Saturday, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Scythian Biosciences earned a media sentiment score of -1.6 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutScythian Biosciences. Who are some of Scythian Biosciences' key competitors? Some companies that are related to Scythian Biosciences include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Admedus (AHZ), Almirall (LBTSF), Amarantus Bioscience (AMBS), Antibe Therapeutics (VBIZF), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Baudax Bio (BXRXV), BerGenBio ASA (BRRGF), Biocure Technology (CURE), Canada House Wellness Group (CHV) and Cannabics Pharmaceuticals (CNBX). View all competitors. What other stocks do shareholders of Scythian Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Scythian Biosciences investors own include Cross Timbers Royalty Trust (CRT), Archer Daniels Midland (ADM), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), OrganiGram (OGI), Roku (ROKU), Scythian Biosciences (SCCYF), Abbott Laboratories (ABT), ARBOR RLTY TR I/SH (ABR) and Aurora Cannabis (ACBFF). Who are Scythian Biosciences' key executives? Scythian Biosciences' management team includes the following people: Mr. Rob Reid, CEO & DirectorMr. Jonathan James Held, Chief Financial Officer (Age 32)Mr. Maghsoud Dariani, Chief Scientific Officer (Age 65)Prof. Michael Barnes, Chief Medical Officer What is Scythian Biosciences' stock symbol? Scythian Biosciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SCYB." How do I buy shares of Scythian Biosciences? Shares of SCYB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Scythian Biosciences' official website? The official website for Scythian Biosciences is scythianbio.com. How can I contact Scythian Biosciences? Scythian Biosciences' mailing address is 366 Bay St Suite 200, TORONTO, ON M5H 4B2, Canada. The company can be reached via phone at +1-416-3669192. This page was last updated on 5/30/2020 by MarketBeat.com Staff
